19 February 2020
There have been reported cases in China of respiratory infections caused by a novel coronavirus (COVID-19), which is classified as an airborne high consequence infectious disease (HCID) in the UK. As of 17 February 2020, nine patients in England have tested positive for coronavirus. Governments and ...
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
9 January 2020
The College’s Annual General Meeting will take place on 29 April 2020 as part of the RCPCH Conference in Liverpool.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
25 October 2019
Next year’s RCPCH Conference will play host to a diverse line-up of prominent speakers who will take to the main stage over the three-day event.
16 October 2019
Withdrawal and Medicines Alerts for Ranitidine Related Products Zantac®, used to treat conditions such as acid reflux in children, has been recalled by its manufacturer because of concerns that it may contain low levels of NDMA.
13 September 2019
RSPH say banning junk food ads, building parks and transforming active travel are key to success. RCPCH's Dr Max Davie responds.
7 September 2019
The RCPCH welcomes the CMO's updated physical activity guidelines and says "the key to longevity and success is embedding healthy habits into life early and making them part of a routine".
30 August 2019
New data from Public Health England reveals 301 new measles cases between April and June 2019. RCPCH's immunisation expert responds.
13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...